Fairbanks Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
25,693
+1,609
| +7% | +$173K | 1.57% | 22 |
|
|
2025
Q1 | $2.43M | Sell |
24,084
-6,133
| -20% | -$619K | 1.56% | 23 |
|
|
2024
Q4 | $2.7M | Buy |
30,217
+748
| +3% | +$66.8K | 1.68% | 21 |
|
|
2024
Q3 | $2.47M | Buy |
29,469
+1,644
| +6% | +$138K | 1.55% | 24 |
|
|
2024
Q2 | $2.14M | Buy |
27,825
+658
| +2% | +$50.7K | 1.41% | 26 |
|
|
2024
Q1 | $1.86M | Sell |
27,167
-423
| -2% | -$29K | 1.28% | 27 |
|
|
2023
Q4 | $1.59M | Buy |
27,590
+1,448
| +6% | +$83.7K | 1.14% | 30 |
|
|
2023
Q3 | $1.38M | Sell |
26,142
-1,243
| -5% | -$65.6K | 1.16% | 27 |
|
|
2023
Q2 | $1.48M | Sell |
27,385
-6,015
| -18% | -$325K | 1.15% | 26 |
|
|
2023
Q1 | $1.67M | Sell |
33,400
-1,346
| -4% | -$67.3K | 1.33% | 22 |
|
|
2022
Q4 | $1.61M | Sell |
34,746
-118
| -0.3% | -$5.46K | 1.43% | 22 |
|
|
2022
Q3 | $1.35M | Sell |
34,864
-426
| -1% | -$16.5K | 1.26% | 26 |
|
|
2022
Q2 | $1.32M | Sell |
35,290
-940
| -3% | -$35K | 1.15% | 27 |
|
|
2022
Q1 | $1.61M | Sell |
36,230
-18
| -0% | -$797 | 1.19% | 26 |
|
|
2021
Q4 | $1.54M | Buy |
36,248
+58
| +0.2% | +$2.46K | 1.12% | 31 |
|
|
2021
Q3 | $1.57M | Buy |
36,190
+1,113
| +3% | +$48.3K | 1.28% | 30 |
|
|
2021
Q2 | $1.5M | Buy |
35,077
+1,770
| +5% | +$75.7K | 1.18% | 32 |
|
|
2021
Q1 | $1.29M | Buy |
33,307
+5,081
| +18% | +$196K | 1.05% | 34 |
|
|
2020
Q4 | $1.02M | Buy |
28,226
+9,881
| +54% | +$355K | 0.91% | 35 |
|
|
2020
Q3 | $701K | Hold |
18,345
| – | – | 0.7% | 44 |
|
|
2020
Q2 | $729K | Buy |
18,345
+553
| +3% | +$22K | 0.71% | 42 |
|
|
2020
Q1 | $581K | Buy |
17,792
+6,670
| +60% | +$218K | 0.76% | 41 |
|
|
2019
Q4 | $503K | Buy |
11,122
+3,509
| +46% | +$159K | 0.52% | 46 |
|
|
2019
Q3 | $310K | Buy |
+7,613
| New | +$310K | 0.32% | 50 |
|